If confirmed, Makary would run one of the nation's leading health agencies, overseeing the regulation of food and drugs.
Questioned by senators at a Thursday hearing, President Trump's FDA nominee said he would reevaluate which scientific topics require an advisory committee's input.
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...
Marty Makary, Trump’s pick for FDA commissioner, testifies before a Senate panel this morning. Follow STAT's live updates.
An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...
Patent Trial and Appeal Board (PTAB) docket entries indicate that the PTAB has invalidated all challenged claims of Moderna’s ...
The U.S. Food and Drug Administration confirmed on Thursday that a meeting of its independent advisory panel to discuss the ...
The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in ...
The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results